These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23622648)

  • 21. Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients.
    Rovira J; Marcelo Arellano E; Burke JT; Brault Y; Moya-Rull D; Bañón-Maneus E; Ramírez-Bajo MJ; Gutiérrez-Dalmau A; Revuelta I; Quintana LF; Campistol JM; Diekmann F
    Transpl Int; 2008 Oct; 21(10):992-8. PubMed ID: 18657090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.
    Lopes P; Fuhrmann A; Sereno J; Pereira MJ; Nunes P; Pedro J; Melão A; Reis F; Carvalho E
    Transplant Proc; 2013 Apr; 45(3):1142-8. PubMed ID: 23622647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.
    Sereno J; Rodrigues-Santos P; Vala H; Rocha-Pereira P; Alves R; Fernandes J; Santos-Silva A; Carvalho E; Teixeira F; Reis F
    Int J Mol Sci; 2014 May; 15(5):8979-97. PubMed ID: 24853130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
    Friend P; Russ G; Oberbauer R; Murgia MG; Tufveson G; Chapman J; Blancho G; Mota A; Grandaliano G; Campistol JM; Brault Y; Burke JT;
    Transpl Int; 2007 Sep; 20(9):754-60. PubMed ID: 17565578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
    Russ G; Jamieson N; Oberbauer R; Arias M; Murgia MG; Blancho G; Sato R; Stoeckl M; Revicki DA
    Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
    Johnson RW; Kreis H; Oberbauer R; Brattström C; Claesson K; Eris J
    Transplantation; 2001 Sep; 72(5):777-86. PubMed ID: 11571437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
    Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
    Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
    Satyanarayana PS; Chopra K
    Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin.
    Ateyya H
    Int Immunopharmacol; 2015 Sep; 28(1):571-7. PubMed ID: 26225924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
    Legendre C; Brault Y; Morales JM; Oberbauer R; Altieri P; Riad H; Mahony J; Messina M; Pussell B; Martínez JG; Lelong M; Burke JT; Neylan JF;
    Clin Transplant; 2007; 21(3):330-6. PubMed ID: 17488381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G; Di Paolo S; Schena A; Infante B; Grandaliano G; Battaglia M; Gesualdo L; Schena FP
    Transplantation; 2003 Apr; 75(7):998-1003. PubMed ID: 12698087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
    Yi T; Cuchara L; Wang Y; Koh KP; Ranjbaran H; Tellides G; Pober JS; Lorber MI
    Transplantation; 2006 Feb; 81(4):559-66. PubMed ID: 16495804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M
    Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of shallot (Allium ascalonicum L.) extract on cyclosporine nephrotoxicity in rats.
    Wongmekiat O; Leelarugrayub N; Thamprasert K
    Food Chem Toxicol; 2008 May; 46(5):1844-50. PubMed ID: 18308444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrocortisone attenuates cyclosporin A-induced nephrotoxicity in rats.
    Ciarcia R; Damiano S; Fiorito F; Granato G; Pagnini F; Mastellone V; Iovane V; Alfano L; Valenti F; Florio S; Giordano A
    J Cell Biochem; 2012 Mar; 113(3):997-1004. PubMed ID: 22034142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
    Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.